1-20 of 27
Stephan J.L. Bakker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comment on Zu et al. Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus. Diabetes Care 2024;47:371–378

Dion Groothof, Thomas Bais, Stephan J.L. Bakker
Journal: Diabetes Care
Diabetes Care 2024;47(10):e84
https://doi.org/10.2337/dc24-1246
Published: 20 September 2024
View article titled, Comment on Zu et al. Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus. Diabetes Care 2024;47:371–378
Open the PDF for Comment on Zu et al. Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus. Diabetes Care 2024;47:371–378 in another window
Journal Articles

Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41

Milou M. Oosterwijk, Dion Groothof, Gerjan Navis, Stephan J.L. Bakker, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2022;45(3):e69
https://doi.org/10.2337/dci21-0062
Published: 04 March 2022
View article titled, Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41
Open the PDF for Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41 in another window
Journal Articles

High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort

Milou M. Oosterwijk, Dion Groothof, Gerjan Navis, Stephan J.L. Bakker, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2022;45(1):35–41
https://doi.org/10.2337/dc21-1211
Published: 28 October 2021
View article titled, High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort
Open the PDF for High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort in another window
Journal Articles

Androgens and Development of Posttransplantation Diabetes Mellitus in Male Kidney Transplant Recipients: A Post Hoc Analysis of a Prospective Study

Suzanne P. Stam, Sara Sokooti, Michele F. Eisenga, Anna van der Veen, António W. Gomes-Neto, Peter R. van Dijk, Jelmer J. van Zanden, Michel J. Vos, Ido P. Kema, André P. van Beek, Stephan J.L. Bakker, TransplantLines Investigators
Journal: Diabetes Care
Diabetes Care 2021;44(12):2683–2690
https://doi.org/10.2337/dc21-0237
Published: 05 October 2021
View article titled, Androgens and Development of Posttransplantation Diabetes Mellitus in Male Kidney Transplant Recipients: A Post Hoc Analysis of a Prospective Study
Open the PDF for Androgens and Development of Posttransplantation Diabetes Mellitus in Male Kidney Transplant Recipients: A Post Hoc Analysis of a Prospective Study in another window
Journal Articles

Glucose Regulation Beyond HbA1c in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort

Niala den Braber, Miriam M.R. Vollenbroek-Hutten, Kathryn M. Westerik, Stephan J.L. Bakker, Gerjan Navis, Bert-Jan F. van Beijnum, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2021;44(10):2238–2244
https://doi.org/10.2337/dc20-2241
Published: 22 July 2021
View article titled, Glucose Regulation Beyond HbA<sub>1c</sub> in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort
Open the PDF for Glucose Regulation Beyond HbA<sub>1c</sub> in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort in another window
Journal Articles

Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)

Jelle M. Beernink, Milou M. Oosterwijk, Kamlesh Khunti, Pankaj Gupta, Prashanth Patel, Job F.M. van Boven, Hiddo J. Lambers Heerspink, Stephan J.L. Bakker, Gerjan Navis, Roos M. Nijboer, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2021;44(6):1419–1425
https://doi.org/10.2337/dc20-2533
Published: 23 April 2021
View article titled, Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
Open the PDF for Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT) in another window
Journal Articles

Statin Use Is Prospectively Associated With New-Onset Diabetes After Transplantation in Renal Transplant Recipients

Tamas Szili-Torok, Stephan J.L. Bakker, Uwe J.F. Tietge
Journal: Diabetes Care
Diabetes Care 2020;43(8):1945–1947
https://doi.org/10.2337/dc19-1212
Published: 22 May 2020
View article titled, Statin Use Is Prospectively Associated With New-Onset Diabetes After Transplantation in Renal Transplant Recipients
Open the PDF for Statin Use Is Prospectively Associated With New-Onset Diabetes After Transplantation in Renal Transplant Recipients in another window
Journal Articles

Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function

Stanley M.H. Yeung, S. Heleen Binnenmars, Christina M. Gant, Gerjan Navis, Ron T. Gansevoort, Stephan J.L. Bakker, Martin H. de Borst, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2019;42(11):2151–2153
https://doi.org/10.2337/dc19-0528
Published: 05 September 2019
View article titled, Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function
Open the PDF for Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function in another window
Includes: Supplementary data
Journal Articles

Fruit and Vegetable Intake and Risk of Posttransplantation Diabetes in Renal Transplant Recipients

António W. Gomes-Neto, Maryse C.J. Osté, Camilo G. Sotomayor, Else v.d. Berg, Johanna M. Geleijnse, Reinold O.B. Gans, Stephan J.L. Bakker, Gerjan J. Navis
Journal: Diabetes Care
Diabetes Care 2019;42(9):1645–1652
https://doi.org/10.2337/dc19-0224
Published: 11 July 2019
View article titled, Fruit and Vegetable Intake and Risk of Posttransplantation Diabetes in Renal Transplant Recipients
Open the PDF for Fruit and Vegetable Intake and Risk of Posttransplantation Diabetes in Renal Transplant Recipients in another window
Includes: Supplementary data
Journal Articles

Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care

Nicole Oosterom, Christina M. Gant, Niels Ruiterkamp, Bert-Jan F. van Beijnum, Hermie Hermens, Stephan J.L. Bakker, Gerjan Navis, Miriam M.R. Vollenbroek-Hutten, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2018;41(4):e50–e51
https://doi.org/10.2337/dc17-2041
Published: 06 February 2018
View article titled, Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care
Open the PDF for Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care in another window
Journal Articles

High Serum PCSK9 Is Associated With Increased Risk of New-Onset Diabetes After Transplantation in Renal Transplant Recipients

Michele F. Eisenga, Dorien M. Zelle, John H. Sloan, Carlo A.J.M. Gaillard, Stephan J.L. Bakker, Robin P.F. Dullaart
Journal: Diabetes Care
Diabetes Care 2017;40(7):894–901
https://doi.org/10.2337/dc16-2258
Published: 01 May 2017
View article titled, High Serum PCSK9 Is Associated With Increased Risk of New-Onset Diabetes After Transplantation in Renal Transplant Recipients
Open the PDF for High Serum PCSK9 Is Associated With Increased Risk of New-Onset Diabetes After Transplantation in Renal Transplant Recipients in another window
Includes: Supplementary data
Journal Articles

Midregional Fragment of Proadrenomedullin, New-Onset Albuminuria, and Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-30)

Gijs W.D. Landman, Peter R. van Dijk, Iefke Drion, Kornelis J.J. van Hateren, Joachim Struck, Klaas H. Groenier, Rijk O.B. Gans, Henk J.G. Bilo, Stephan J.L. Bakker, Nanne Kleefstra
Journal: Diabetes Care
Diabetes Care 2014;37(3):839–845
https://doi.org/10.2337/dc13-1852
Published: 11 February 2014
View article titled, Midregional Fragment of Proadrenomedullin, New-Onset Albuminuria, and Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-30)
Open the PDF for Midregional Fragment of Proadrenomedullin, New-Onset Albuminuria, and Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-30) in another window
Journal Articles

Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)

Ineke J. Riphagen, PHARMD, Wendy E. Boertien, MD, Alaa Alkhalaf, MD, Nanne Kleefstra, MD, Ron T. Gansevoort, MD, Klaas H. Groenier, PHD, Kornelis J.J. van Hateren, MD, Joachim Struck, PHD, Gerjan Navis, MD, Henk J.G. Bilo, MD, Stephan J.L. Bakker, MD
Journal: Diabetes Care
Diabetes Care 2013;36(10):3201–3207
https://doi.org/10.2337/dc12-2165
Published: 14 September 2013
View article titled, Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)
Open the PDF for Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31) in another window
Includes: Supplementary data
Journal Articles

Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation

Dorien M. Zelle, MSC, Eva Corpeleijn, PHD, Jolijn Deinum, MSC, Ronald P. Stolk, MD, PHD, Rijk O.B. Gans, MD, PHD, Gerjan Navis, MD, PHD, Stephan J.L. Bakker, MD, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(7):1926–1932
https://doi.org/10.2337/dc12-1894
Published: 12 June 2013
View article titled, Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation
Open the PDF for Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation in another window
Journal Articles

Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy

Steef J. Sinkeler, MD, Arjan J. Kwakernaak, MD, Stephan J.L. Bakker, MD, Shahnaz Shahinfar, MD, Enric Esmatjes, MD, Dick de Zeeuw, MD, Gerjan Navis, MD, Hiddo J. Lambers Heerspink, PHARMD
Journal: Diabetes Care
Diabetes Care 2013;36(6):1489–1494
https://doi.org/10.2337/dc12-1545
Published: 15 May 2013
View article titled, Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy
Open the PDF for Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy in another window
Includes: Supplementary data
Journal Articles

The Midregional Fragment of Pro-A–Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25)

Kornelis J.J. van Hateren, MD, Gijs W.D. Landman, MD, Nanne Kleefstra, MD, Klaas H. Groenier, PHD, Joachim Struck, PHD, Gerjan J. Navis, MD, Stephan J.L. Bakker, MD, Sebastiaan T. Houweling, MD, Klaas van der Meer, MD, Henk J.G. Bilo, MD
Journal: Diabetes Care
Diabetes Care 2013;36(5):1347–1352
https://doi.org/10.2337/dc12-0428
Published: 13 April 2013
View article titled, The Midregional Fragment of Pro-A–Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25)
Open the PDF for The Midregional Fragment of Pro-A–Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25) in another window
Journal Articles

Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes

Merel E. Hellemons, MD, Magdalena Mazagova, PHD, Ron T. Gansevoort, MD, Robert H. Henning, MD, Dick de Zeeuw, MD, Stephan J.L. Bakker, MD, Hiddo J. Lambers-Heerspink, PHD, Leo E. Deelman, PHD
Journal: Diabetes Care
Diabetes Care 2012;35(11):2340–2346
https://doi.org/10.2337/dc12-0180
Published: 13 October 2012
View article titled, Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes
Open the PDF for Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes in another window
Journal Articles

Plasma COOH-Terminal Proendothelin-1: A marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)

Iefke Drion, MD, Nanne Kleefstra, MD, Gijs W.D. Landman, MD, Alaa Alkhalaf, MD, Joachim Struck, PHD, Klaas H. Groenier, PHD, Stephan J.L. Bakker, MD, Henk J.G. Bilo, MD
Journal: Diabetes Care
Diabetes Care 2012;35(11):2354–2358
https://doi.org/10.2337/dc11-2526
Published: 13 October 2012
View article titled, Plasma COOH-Terminal Proendothelin-1: <subtitle>A marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)</subtitle>
Open the PDF for Plasma COOH-Terminal Proendothelin-1: <subtitle>A marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)</subtitle> in another window
Journal Articles

One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic Kidney Disease

Marjan Alssema, PHD, Rachel S. Newson, PHD, Stephan J.L. Bakker, MD, Coen D.A. Stehouwer, MD, Martijn W. Heymans, PHD, Giel Nijpels, MD, Hans L. Hillege, MD, Albert Hofman, MD, Jacqueline C.M. Witteman, PHD, Ron T. Gansevoort, MD, Jacqueline M. Dekker, PHD
Journal: Diabetes Care
Diabetes Care 2012;35(4):741–748
https://doi.org/10.2337/dc11-1417
Published: 13 March 2012
View article titled, One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic Kidney Disease
Open the PDF for One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic Kidney Disease in another window
Includes: Supplementary data
Journal Articles

Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A post hoc analysis of the IRMA-2 trial

Merel E. Hellemons, MD, Frederik Persson, MD, Stephan J.L. Bakker, MD, Peter Rossing, MD, Hans-Henrik Parving, MD, Dick De Zeeuw, MD, Hiddo J. Lambers Heerspink, PHARMD
Journal: Diabetes Care
Diabetes Care 2011;34(9):2078–2083
https://doi.org/10.2337/dc11-0324
Published: 19 August 2011
View article titled, Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: <subtitle>A post hoc analysis of the IRMA-2 trial</subtitle>
Open the PDF for Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: <subtitle>A post hoc analysis of the IRMA-2 trial</subtitle> in another window